Microdosing has moved from a forum discussion to a product category, with dedicated programmes from Noom, PlexusDx, Fitish and others. It is a real clinical idea being sold well ahead of the evidence, and it is worth understanding both halves of that sentence.
What microdosing actually means
In GLP-1 terms, microdosing means staying at a dose below the standard therapeutic range rather than titrating up to it. Standard semaglutide titration starts at 0.25mg weekly as a tolerance-building step and climbs toward 1.7mg or 2.4mg. A microdose programme keeps you at or near that starting level indefinitely, and typically does not titrate at all.
Fitish RX describes its microdose lane explicitly as a lower fixed dose that does not titrate up, positioned as a gentle, mindful, cosmetic approach rather than full-dose weight loss. That is an unusually clear description of what these programmes are.
Why providers are selling it
Three reasons, and they are worth separating.
Tolerability
Most GLP-1 side effects cluster during dose escalation. Staying low avoids the worst of the nausea, fatigue and constipation described in our side effects guide.
Cost
Less active ingredient means a cheaper preparation. PlexusDx prices its microdose protocol at $129 a month against $149 for standard semaglutide and $249 for tirzepatide.
Market expansion
A microdose programme can be offered to people who do not meet the BMI criteria for full-dose treatment, which is a much larger addressable market.
Maintenance
Some patients who have reached a goal weight use a lower dose to hold it, which is a genuinely different clinical situation from starting low.
The third reason deserves scrutiny
Fitish states plainly that patients whose BMI falls below the threshold for its compounded GLP-1 programme may still be candidates for microdosing. That is a commercial pathway for people a clinician has effectively screened out of standard treatment. It is disclosed honestly, which is to the provider's credit, and it is still a decision to make deliberately rather than by default.
What the evidence does and does not show
The large trials that established GLP-1 efficacy studied full therapeutic doses. STEP 1 reported roughly 14.9 percent mean weight loss with FDA-approved semaglutide at 2.4mg over 68 weeks. SURMOUNT-1 reported roughly 20.9 to 22.5 percent with tirzepatide at 15mg over 72 weeks. Neither studied a sustained low fixed dose as a treatment strategy.
What the dose-ranging data does show is that response is dose-dependent: lower doses produce less weight loss on average. So a microdose programme is not a cheaper way to get the same result. It is a different, smaller result, chosen deliberately.
There is a reasonable clinical case for low-dose use in specific situations, including poor tolerance at higher doses and maintenance after reaching a goal weight. What does not currently exist is trial evidence supporting microdosing as a primary strategy for people who do not meet standard treatment criteria.
Who offers a microdose programme, and what it costs
| Provider | Programme | Published price |
|---|---|---|
| PlexusDx | Microdose GLP-1 Protocol, all-inclusive | $129/mo |
| Fitish RX | Microdose semaglutide, fixed dose, no titration | $179 per 28-day supply |
| Noom Med | Noom Microdose, coaching-led | Reported at around $199/mo, with a lower first month |
| Shed | Microdose GLP-1, weekly low-dose injection | Not published separately |
Prices reflect what each provider published at the time of writing and change frequently. Confirm directly before enrolling.
Note the pricing pattern: microdose programmes are cheaper than standard ones but not dramatically so, typically 15 to 50 percent less. Because the active ingredient is the main cost difference and clinical overhead is unchanged, you are paying a similar service fee for less medication.
Questions to ask before starting a microdose programme
- What dose will I actually be on, in milligrams per week?
- Is this a fixed dose that never titrates, or a starting point that can increase?
- Would I qualify for the standard full-dose programme, and if not, why not?
- What weight-loss outcome is realistic at this dose, as distinct from trial figures for full doses?
- Is this intended as a starting strategy, a tolerance accommodation, or maintenance after reaching a goal?
- What is the plan if I see no response after eight to twelve weeks?
Microdosing versus simply titrating slowly
These are often conflated and should not be. Titrating slowly means moving up the standard ladder at a gentler pace because of side effects, with a therapeutic dose still as the destination. Microdosing means the low dose is the destination. Both are legitimate; only one of them is aiming at the outcomes the trials measured.
If your reason for considering a microdose is tolerance, discuss extending your titration schedule with your provider before switching to a different product. A flat-rate provider that does not charge more at higher doses removes the financial reason to stay low, and our flat-rate pricing comparison covers which ones do that.
Where we land
Microdosing is a reasonable option in narrow circumstances: poor tolerance at standard doses, or maintenance after reaching a goal weight, both under clinician supervision. It is a weaker proposition as a way for people who do not meet treatment criteria to obtain a prescription medication, and that is increasingly what it is being marketed as. The programmes are honest about the dose being low; be equally honest with yourself about what you are expecting from it.
Frequently Asked Questions
What is GLP-1 microdosing?
Taking a GLP-1 medication at a dose below the standard therapeutic range on an ongoing basis, rather than titrating up to a full dose. Most microdose programmes use a fixed dose that does not increase.
Does microdosing work for weight loss?
Less than full-dose treatment. GLP-1 response is dose-dependent, and the large trials that established efficacy studied full therapeutic doses. Microdosing is a smaller expected result chosen deliberately, not a cheaper route to the same one.
Who offers GLP-1 microdosing?
PlexusDx offers a Microdose GLP-1 Protocol at $129 a month, Fitish RX a fixed-dose microdose semaglutide programme at $179 per 28 days, Noom a Microdose programme, and Shed lists microdose GLP-1 among its products.
Is microdosing cheaper?
Somewhat. Microdose programmes typically cost 15 to 50 percent less than standard ones. Because clinical overhead is unchanged and only the medication quantity falls, the saving is smaller than the dose difference suggests.
Can I microdose if my BMI is too low for standard treatment?
Some providers explicitly offer this, and Fitish RX states so directly. Whether it is appropriate is a clinical judgement, and it is worth asking your provider why you did not qualify for standard treatment before proceeding on a lower dose.
Is microdosing the same as titrating slowly?
No. Titrating slowly means reaching a therapeutic dose at a gentler pace. Microdosing means the low dose is the intended destination.
Is microdosing safer?
Side effects generally cluster during dose escalation, so staying low tends to mean fewer of them. That is not the same as being risk-free: the contraindications for GLP-1 medications apply at any dose, and a clinician still needs to screen you.
Medical Disclaimer
This article is for general information only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with real risks and contraindications. Only a licensed clinician who knows your history can decide whether any medication is appropriate for you. Pricing, programmes and policies described here reflect what providers published at the time of writing and change frequently; verify everything directly before enrolling. See our full medical disclaimer.